#Japan #Tokyo #EverBridge Group #Cosmotec #Japan Medical

EverBridge Group and Cosmotec Form Groundbreaking Partnership

In a significant move for the healthcare sector, EverBridge Group has announced an exclusive marketing partnership with Cosmotec Inc., a wholly-owned subsidiary of M3, Inc. This collaboration, revealed on September 15, 2025, marks a pivotal moment in EverBridge's strategy to expand its footprint in the Japanese market.

This strategic alliance emphasizes EverBridge Group's commitment to innovation and compliance, ensuring that their cutting-edge medical technologies reach a broader audience. The partnership is not only a testament to EverBridge's leadership within the industry but also a response to the evolving needs of healthcare providers and patients in Japan.

The Vision Behind the Partnership

The alliance aims to leverage Cosmotec's robust digital marketing platform, which significantly accelerates market access for international medical products. By facilitating targeted outreach to clinical end-users, this partnership is poised to streamline the introduction of new therapeutic solutions to Japanese healthcare professionals.

Suguru Ominato, CEO of Cosmotec, expressed enthusiasm about the collaboration, stating, "The EverBridge Group's portfolio is characterized by outstanding clinical efficiency and user-friendly design, perfectly aligning with the aspirations of Japanese physicians seeking advanced therapeutic options. By fusing M3's academic platforms with our localized marketing expertise, we aim to expedite the adoption of these devices across Japan."

Enhancing Healthcare Accessibility

Jay Wang, CEO of EverBridge Group, emphasized the importance of providing efficient and accessible solutions in healthcare. "Cosmotec’s digital marketing model not only offers improved accessibility but aligns seamlessly with our vision of equitable healthcare innovation. Navigating Japan's stringent technical and regulatory landscape will empower us to deliver transformative solutions for patients while fostering our global strategic alliances. Lowering the barriers to advanced care through innovation and ecosystem collaboration remains a cornerstone of our globalization strategy."

A Diverse Product Portfolio

EverBridge Group stands out as a prominent player in the medical technology landscape of Asia, dedicated to delivering state-of-the-art, high-quality, and affordable medical solutions to global customers. The company’s expanding product portfolio encompasses three major therapeutic areas: peripheral vascular, neurology, and oncology. Supported by six specialized FE and lean manufacturing centers, EverBridge offers best-in-class OEM/ODM services in various domains, including balloons, catheters, stents, surface technology, and active medical equipment.

The company collaborates closely with leading organizations worldwide, acting as a bridge for medical technology innovations between Asia and other regions. EverBridge's overarching goal is to provide healthcare professionals and patients with enhanced treatment options through advanced and accessible solutions.

For more details on EverBridge Group and its innovations, visit their official website at www.everbridgemed.com. For media inquiries, reach out to Ann Chen at [email protected]